143008-58-6

Basic information

• Product Name: 2-Propen-1-one, 2-(nitromethyl)-1,3-diphenyl-, (E)-
• CAS NO: 143008-58-6
• Molecular Formula: C16H13NO3
• Molecular Weight: 267.284
• Mol File: 143008-58-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-Propen-1-one, 2-(nitromethyl)-1,3-diphenyl-, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propen-1-one, 2-(nitromethyl)-1,3-diphenyl-, (E)-(143008-58-6)
• EPA Substance Registry System: 2-Propen-1-one, 2-(nitromethyl)-1,3-diphenyl-, (E)-(143008-58-6)

Safety Data

• Hazardous Substances Data: 143008-58-6(Hazardous Substances Data)

Upstream product

• 93-55-0 1-phenyl-propan-1-one 
• 100-52-7 benzaldehyde 
• 14182-01-5 (2E)-2-methyl-1,3-diphenylprop-2-en-1-one 
• 21596-41-8 (Z)-2-(bromomethyl)-1,3-diphenylprop-2-en-1-one 

Downstream Products

• 143008-44-0 (R)-2-Methylene-1,3-diphenyl-heptan-1-one 
• 143008-44-0 (S)-2-Methylene-1,3-diphenyl-heptan-1-one 
• 143008-45-1 1-phenyl-2-(1-phenylethyl)-2-propen-1-one 
• 143008-27-9 (E)-2-((S)-2-Methoxymethoxymethyl-pyrrolidin-1-ylmethyl)-1,3-diphenyl-propenone 
• 143008-28-0 (E)-2-((S)-2-Methylsulfanylmethyl-pyrrolidin-1-ylmethyl)-1,3-diphenyl-propenone 
• 143008-26-8 (E)-2-((S)-2-Methoxymethyl-pyrrolidin-1-ylmethyl)-1,3-diphenyl-propenone 

Relevant articles and documents

Design, Synthesis, and Biological Evaluation of Organic Nitrite (NO 2-) Donors as Potential Anticerebral Ischemia Agents

The treatment of ischemic stroke (IS) remains a big challenge in clinics, and it is urgently needed to develop novel, safe, and effective medicines against IS. Here, we report the design, synthesis, and biological evaluation of organic NO2- donors as potential agents for the treatment of IS. The representative compound 4a was able to slowly generate low concentrations of NO2- by reaction with a thiol-containing nucleophile, and the NO2- was selectively converted into NO under ischemic/hypoxia conditions to protect primary rat neurons from oxygen-glucose deprivation and recovery (OGD/R)-induced cytotoxicity by enhancing the Nrf2 signaling and activating the NO/cGMP/PKG pathway. Treatment with 4a at 2 h before or after ischemia mitigated the ischemia/reperfusion-induced brain injury in middle cerebral artery occlusion (MCAO) rats by producing NO and enhancing Nrf2 signaling. Furthermore, 4a significantly promoted endothelial cell proliferation and angiogenesis within the ischemic penumbra. Our findings suggest that this type of NO2- donors, like 4a, may be valuable to fight IS and other ischemic diseases.